Trulicity

Trulicity is the brand name for dulaglutide, a once‑weekly injectable glucagon‑like peptide‑1 (GLP‑1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Trulicity also has indications related to reducing major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease or multiple risk factors.